The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations

For patients with epidermal growth factor receptor (EGFR) mutation-positive lung cancer, the relationship between the dose or duration of treatment with tyrosine kinase inhibitor (TKI) and overall survival remains unclear. Here, we analyzed clinical data of 39 patients who were diagnosed with EGFR m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Suzuki, Hidekazu, Hirashima, Tomonori, Okamoto, Norio, Yamadori, Tadahiro, Tamiya, Motohiro, Morishita, Naoko, Shiroyama, Takayuki, Otsuka, Tomoyuki, Kitai, Kanako, Kawase, Ichiro
Formato: Artigo
Idioma:Inglês
Publicado em: Sun Yat-sen University Cancer Center 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3845597/
https://ncbi.nlm.nih.gov/pubmed/23237215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.012.10160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados